Abstract:TO THE EDITOR—Brucellosis is a common zoonotic disease worldwide [1]. The epidemiology of human brucellosis has drastically changed owing to changing sanitary and socioeconomic conditions, and the substantial increase in international travel. New foci of human brucellosis have emerged or reemerged, with brucellosis becoming a travel-related disease, particularly in nonendemic areas [2–4]. Awareness of the geographic distribution and characteristics of brucellosis is valuable not only for the disease control in endemic areas, but also for preventing and diagnosing travel-associated disease in nonendemic areas [5, 6]. To investigate the geographic distribution of the human brucellosis epidemic in China, data were extracted from the National Notifiable Disease Surveillance System and analyzed. From December 2004 to July 2010, 141 604 laboratoryconfirmed cases were reported. A geographic distribution analysis showed that brucellosis is mainly distributed in some of the northern provinces of China. The 5 provinces with the highest incidence include Inner Mongolia (45.83%), Shanxi (13.94%), Heilongjiang (13.82%), Jilin (10.29%), and Hebei (6.31%); these provinces accounted for >90% of the reported cases. Nationwide, the annual incidence, at a county level, ranged from 0.00 to 1395.84 per 100 000 (Figure 1). Timely diagnosis is important for treating brucellosis and preventing chronic infections [7]. We examined the case data for possible contributing factors to delayed diagnoses. Of these 141 604 confirmed cases, only 26.98% were diagnosed within 7 days of symptom onset, 43.83% within 14 days, and 2.39% longer than 6 months, indicating that a large proportion of the cases had a delayed diagnosis. Further analysis showed that the average diagnosis delay was shorter in the high-incidence areas than in the low-incidence areas (35 vs 59 days, P < .001), and shorter in urban areas than in villages (32.55 vs 40.62 days, P < .001). In addition, patients who traveled or migrated across provinces had longer delays than did patients residing within an area (43.54 vs 36.82 days, P < .001). These data indicated that diagnosis delays were multifactorial and may have contributed to the chronicity of brucellosis in some population segments. Epidemiological information regarding 2060 cases were collected from brucellosis clinics and analyzed to investigate the reasons for the delays in diagnosis. Surprisingly, 57.62% of the patients had been misdiagnosed or suspected of having other diseases with similar clinical symptoms. Approximately 24.34% of the “delayed diagnosis” patients had traveled to or migrated from a high-risk area. All the patients had experienceddirect contactwith animals and/or consumed contaminated animal products prior to disease onset. The absence of characteristic symptoms and a general unawareness of epidemiological information contributed to the misdiagnoses. The lackof typical clinicalmanifestations makes it difficult to diagnose brucellosis, primarily contributing to the misdiagnosis and delay. The availability of additional information regarding the geographic

Amelioration of Renal Injury and Oxidative Stress by the nNOS Inhibitor L-VNIO in the Salt-sensitive mRen2.Lewis Congenic Rat

Inequity in Healthcare Needs, Health Service Use and Financial Burden of Medical Expenditures in China: Results from a Consecutive Household Monitoring Study in Jiangsu Province

Factors influencing length of stay and costs in inpatient cases of human brucellosis as the primary diagnosis over a decade in Beijing, China

Economic Burden and Health Care Access for Patients with Inflammatory Bowel Diseases in China: Web-Based Survey Study

[Medical costs of brucellosis patients in Datong of Shanxi province, 2017-2019]

Changing Epidemiology Of Human Brucellosis, China, 1955-2014

Lack of Objective Evidence of Efficacy of Laxatives in Chronic Constipation

[Currency Survey and Influencing Factors Analysis on the Knowledge and Behavior Related to Brucellosis among Occupational Workers in Jianyang City]

Out-of-pocket Payments and Economic Consequences from Tuberculosis Care in Eastern China: Income Inequality.

Epidemiological characteristics, clinical manifestations and laboratory findings in 850 patients with brucellosis in Heilongjiang Province, China

Epidemiological, Clinical and Laboratory Characteristics of Patients with Brucella Infection in Anhui Province, China

Human Brucellosis, a Heterogeneously Distributed, Delayed, and Misdiagnosed Disease in China.

An estimate of the incidence and quantitative risk assessment of human brucellosis in mainland China

How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives.

Disparity in reimbursement for tuberculosis care among different health insurance schemes: evidence from three counties in central China

Epidemiology characterization and risk factors of brucellosis among older rural populations in northwest China

54 An experimental model in gene therapy using HSV1-thymidinekinase-transduced cells

A Systematic Review and Meta-Analysis of Epidemiology and Clinical Manifestations of Human Brucellosis in China

Spatiotemporal distribution of human brucellosis in Inner Mongolia, China, in 2010–2015, and influencing factors

Brucellosis: clinical analysis of 35 cases

Analysis of the Epidemiological, Clinical Characteristics, Treatment and Prognosis of Human Brucellosis During 2014-2018 in Huludao, China